| Abstract O46 – Table 1. Change in total lymphocyte counts and CD4+ T‐cell counts in treatment‐naïve participants with HIV‐1, MK‐8591‐011 parts 1 and 2 (through week 72). | ||
|---|---|---|
| Total lymphocyte counts (109 cells/L) | ||
| Treatment group | N | Mean % change from baseline (95% CI)a |
| DOR/3TC/TDF | 22 | 15.9 (2.0, 29.9) |
| ISL 0.25 mg + DOR 100 mg (+/‐ 3TC) | 19 | 20.5 (4.3, 36.6) |
| ISL 0.75 mg + DOR 100 mg (+/‐ 3TC) | 19 | ‐0.4 (‐14.9, 14.1) |
| ISL 2.25 mg + DOR 100 mg (+/‐ 3TC) | 16 | ‐15.9 (‐31.9, 0.1) |
| CD4+ T‐cell counts (cells/mm3) | ||
| Treatment group | N | Mean % change from baseline (95% CI)a |
| DOR/3TC/TDF | 22 | 60.1 (40.2, 80.0) |
| ISL 0.25 mg + DOR 100 mg (+/‐ 3TC) | 19 | 79.8 (50.0, 109.6) |
| ISL 0.75 mg + DOR 100 mg (+/‐ 3TC) | 18 | 47.1 (26.1, 68.2) |
| ISL 2.25 mg + DOR 100 mg (+/‐ 3TC) | 16 | 24.0 (4.7, 43.4) |
aThe within‐group 95% CIs were calculated based on the t‐distribution.